Vedolizumab May Offer Hope for People with Colitis or Crohn’s Disease

One experimental drug that has been developed may be the answer for patients affected by inflammatory bowel disease that have been unresponsive to current medications. The drug is known as vedolizumab and is being developed to treat two forms of IBD – ulcerative colitis and Crohn’s Disease.

Both of these diseases occur in the digestive tract and can lead to chronic inflammation, abdominal cramps, diarrhea, and rectal bleeding. During new trials, researchers have discovered that vedolizumab had succeeded in cases where standard medications have been ineffective.

The drug was reported to be more effective for colitis than for Crohn’s. The drug may receive FDA approval for the treatment of colitis first. This is a potential new solution for the 2,000 patients that have either colitis or Crohn’s and have failed to see improvements from standard medications.

During a single trial, 47 percent of a group of 900 colitis patients given vedolizumab infusions reported a decrease in symptoms.

Our Blogs

Checking Your Digestive Tract Starts with a Camera

Yes, a camera you can swallow is a real thing. Some parts of the digestive tract can be harder to visualize with traditional testing. That's where capsule endoscopy comes in. The process involves swallowing a small capsule containing a light and camera. As it travels...

Stop Blaming Your Last Meal

Your stomach hurts, so you blame lunch. Again. Was it the coffee? The dairy? The spicy food? Stress? That random snack from yesterday? When digestive symptoms keep coming back, it's easy to put one food on trial every time you feel uncomfortable. But one meal doesn't...

Your Gut Keeps Receipts

Your stomach hurts again. So you blame lunch.Then coffee.Then stress.Then that one thing you ate three days ago. But when digestive symptoms keep returning, the most important question may not be, "What did I eat?" It may be: What's the pattern? Pay attention to...